4578 logo

Otsuka Holdings Co., Ltd. Stock Price

TSE:4578 Community·JP¥4.8t Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

4578 Share Price Performance

JP¥0
-8585.00 (-100.00%)
JP¥11,000.00
Fair Value
JP¥0
-8585.00 (-100.00%)
Price JP¥0

4578 Community Narratives

AnalystHighTarget·
Fair Value JP¥11k 17.1% undervalued intrinsic discount

Digital Health And Aging Trends Will Open Markets Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value JP¥9.58k 4.8% undervalued intrinsic discount

Pharmaceutical Expansion Will Unlock Global Healthcare Opportunities Despite Risks

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value JP¥8k 14.0% overvalued intrinsic discount

Global Healthcare Cost Controls Will Crush Profitability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JP¥8k
14.0% overvalued intrinsic discount
Revenue
-2.01% p.a.
Profit Margin
10.07%
Future PE
20.17x
Price in 2028
JP¥9.21k
JP¥9.58k
4.8% undervalued intrinsic discount
Revenue
2.43% p.a.
Profit Margin
13.1%
Future PE
16.25x
Price in 2028
JP¥11.02k

Trending Discussion

Updated Narratives

4578 logo

4578: Rising Profit Margin Outlook Will Eventually Fail To Justify Lofty Share Price

Fair Value: JP¥8k 14.0% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
4578 logo

4578: Revenue Outlook And Regulatory Milestones Will Shape Near-Term Performance

Fair Value: JP¥9.58k 4.8% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
4578 logo

Digital Health And Aging Trends Will Open Markets Despite Risks

Fair Value: JP¥11k 17.1% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

1 Risk
3 Rewards

Otsuka Holdings Co., Ltd. Key Details

JP¥2.4t

Revenue

JP¥684.1b

Cost of Revenue

JP¥1.7t

Gross Profit

JP¥1.3t

Other Expenses

JP¥449.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 13, 2026
850.37
71.72%
18.57%
4.2%
View Full Analysis

About 4578

Founded
1921
Employees
35338
CEO
Makoto Inoue
WebsiteView website
www.otsuka.com

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, the company offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Tokyo, Japan.

Recent 4578 News & Updates

Recent updates

No updates

Otsuka Holdings Co., Ltd. Competitors